Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Alpha Tau Medical Ltd.

    NASDAQ: DRTS · Real-Time Price · USD
    2.96
    -0.04 (-1.22%)
    At close: Jun 17, 2025, 3:59 PM
    2.96
    0.00%
    After-hours: Jun 17, 2025, 04:04 PM EDT

    Alpha Tau Medical Statistics

    Share Statistics

    Alpha Tau Medical has 84.7M shares outstanding. The number of shares has increased by 0.84% in one year.

    Shares Outstanding

    n/a
    		 84.7M

    Shares Change (YoY)

    n/a
    		 0.84%

    Shares Change (QoQ)

    n/a
    		 0.65%

    Owned by Institutions (%)

    n/a
    		 1.4%

    Shares Floating

    n/a
    		 50.92M

    Failed to Deliver (FTD) Shares

    n/a
    		 11,726

    FTD / Avg. Volume

    n/a
    		 28.1%

    Short Selling Information

    The latest short interest is 97.25K, so 0.11% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 97.25K

    Short % of Shares Out

    n/a
    		 0.11%

    Short % of Float

    n/a
    		 0.15%

    Short Ratio (days to cover)

    n/a
    		 1.53

    Valuation Ratios

    The PE ratio is -6.83 and the forward PE ratio is -8.69. Alpha Tau Medical's PEG ratio is -0.96.

    PE Ratio

    n/a
    		 -6.83

    Forward PE

    n/a
    		 -8.69

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 1.5

    PB Ratio

    n/a
    		 3.46

    P/FCF Ratio

    n/a
    		 -9.84

    PEG Ratio

    n/a
    		 -0.96
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Alpha Tau Medical.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 7.4, with a Debt / Equity ratio of 0.2.

    Current Ratio

    n/a
    		 7.4

    Quick Ratio

    n/a
    		 7.4

    Debt / Equity

    n/a
    		 0.2

    Debt / EBITDA

    n/a
    		 -0.41

    Debt / FCF

    n/a
    		 -0.57

    Interest Coverage

    n/a
    		 -104.77

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-254,000

    Employee Count

    n/a
    		 125

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 6K

    Effective Tax Rate

    n/a
    		 -0.02%

    Stock Price Statistics

    The stock price has increased by 33.33% in the last 52 weeks. The beta is 0.99, so Alpha Tau Medical's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.99

    52-Week Price Change

    n/a
    		 33.33%

    50-Day Moving Average

    n/a
    		 2.8

    200-Day Moving Average

    n/a
    		 2.76

    Relative Strength Index (RSI)

    n/a
    		 52.39

    Average Volume (20 Days)

    n/a
    		 41,728

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -1.1M

    Operating Income

    n/a
    		 -36.04M

    Net Income

    n/a
    		 -31.75M

    EBITDA

    n/a
    		 -30.3M

    EBIT

    n/a
    		 -31.4M

    Earnings Per Share (EPS)

    n/a
    		 -0.45
    Full Income Statement

    Balance Sheet

    The company has 13.72M in cash and 12.54M in debt, giving a net cash position of 1.19M.

    Cash & Cash Equivalents

    n/a
    		 13.72M

    Total Debt

    n/a
    		 12.54M

    Net Cash

    n/a
    		 1.19M

    Retained Earnings

    n/a
    		 -147.51M

    Total Assets

    n/a
    		 86.2M

    Working Capital

    n/a
    		 55.55M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -19.78M and capital expenditures -2.24M, giving a free cash flow of -22.02M.

    Operating Cash Flow

    n/a
    		 -19.78M

    Capital Expenditures

    n/a
    		 -2.24M

    Free Cash Flow

    n/a
    		 -22.02M

    FCF Per Share

    n/a
    		 -0.31
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    DRTS does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for DRTS is $8, which is 166.7% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $8

    Price Target Difference

    n/a
    		 166.7%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 3.59

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist